Topical Innovation: A Report on Epinastine Eyelid Cream for Patients With Mild Atopic Keratoconjunctivitis. [PDF]
Mimura T, Fukagawa K.
europepmc +1 more source
Tacrolimus Ophthalmic Suspension Can Be an Effective Treatment Option for Biologic-Induced Refractory Conjunctivitis. [PDF]
Mima Y, Yamamoto M, Iozumi K.
europepmc +1 more source
Microbiome of the Ocular Surface: Resident or Transient Ecosystem? [PDF]
Apuy Rodríguez F +4 more
europepmc +1 more source
Ocular toxicity associated with antibody-drug conjugates in cancer therapy: a comprehensive review. [PDF]
Zhou J, Wang H, Xie H, Xu X, Xiao H.
europepmc +1 more source
Shield ulcer in keratoconus in the absence of atopic or vernal kerato-conjunctivitis. [PDF]
Niestrata M +3 more
europepmc +1 more source
Two-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin). [PDF]
Guttman-Yassky E +14 more
europepmc +1 more source
The Safety Data of Dupilumab for the Treatment of Moderate‑to‑Severe Atopic Dermatitis in Infants, Children, Adolescents, and Adults. [PDF]
Langley RG +10 more
europepmc +1 more source
AI in conjunctivitis research: assessing ChatGPT and DeepSeek for etiology, intervention, and citation integrity via hallucination rate analysis. [PDF]
Hasnain M +4 more
europepmc +1 more source
Comparison of allergy prevalence using brinzolamide 1.0% / brimonidine 0.2% fixed combination with and without β-blocker in glaucoma patients: a retrospective cohort study. [PDF]
Park IK +5 more
europepmc +1 more source
Corneal biomechanics in patients with allergic conjunctivitis. [PDF]
Wan Abdul Halim WH +2 more
europepmc +1 more source

